MN/CA IX-specific monoclonal antibodies generated from MN/CA IX-deficient mice and methods of use
Details for Australian Patent Application No. 2003217606 (hide)
International Classifications
Event Publications
31 July 2003 Complete Application Filed
Priority application(s): 60/358,824 05.12.02 US; 60/383,068 23.05.02 US
5 February 2004 Application Open to Public Inspection
Published as AU-B-2003217606
18 November 2004 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 20 Sep 2004
27 January 2005 Section 223 Application Received
Institute of Virology An application to extend the time from 03 Dec 2003 to 03 Nov 2004 in which to comply with Section 6(c) has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
17 March 2005 Section 223 Application Allowed
Institute of Virology The time in which to comply with Section 6(c) has been extended to 03 Nov 2004. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
22 November 2007 Application Accepted
Published as AU-B-2003217606
20 December 2007 Corrigenda
Applications Accepted - Name Index Under the name Institute of Virology, Application No. 2003217606, under INID (72), correct the invention title to read MN/ CA IX-specific monoclonal antibodies generated from MN/CA IXdeficient mice methods of use and under INID (30), correct the priority data to read 60/358,824 US 21 Feb 2002, 60/431,499 US 5 Dec 2002 and 60/383,068 US 23 May 2002
10 January 2008 Corrigenda
Applications Accepted - Name Index Under the name Institute of Virology, Application No. 2003217606, under INID (54), correct the invention title to read Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IXs Coexpression with HER-2/nue/c-erbB-2 and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes
24 January 2008 Corrigenda
Applications Accepted - Name Index Under the name Institute of Virology, Application No. 2003217606, under INID (54), correct the invention title to read Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IXs Coexpression with HER-2/neu/c-erbB-2 and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes
13 March 2008 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 10 Jan 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
20 March 2008 Standard Patent Sealed
17 July 2008 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 10 Jan 2008
25 September 2008 Corrigenda
Applications Accepted - Name Index Under the Name Institute of Virology, Application No. 2003217606, Under INID (22), correct the date of filing application to 21 February 2003
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003217607-Methods for preventing or treating cardiac arrhythmia
2003217605-Process and catalyst for production of formaldehyde from dimethyl ether
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser